{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:52:26Z","timestamp":1784141546241,"version":"3.55.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","award":["75N91019D00024 \/ HHSN261201500003I"],"award-info":[{"award-number":["75N91019D00024 \/ HHSN261201500003I"]}],"id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.isci.2025.112232","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T04:13:22Z","timestamp":1742271202000},"page":"112232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Highly immunogenic DNA\/LION nanocarrier vaccine potently activates lymph nodes inducing long-lasting immunity in macaques"],"prefix":"10.1016","volume":"28","author":[{"given":"Sevasti","family":"Karaliota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Rosati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhi","family":"Devasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine C.","family":"Goldfarbmuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer","family":"Bear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Stellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Deleage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit P.","family":"Khandhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Erasmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N.","family":"Pavlakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8925-8128","authenticated-orcid":false,"given":"Barbara K.","family":"Felber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.112232_bib1","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/vaccines2020354","article-title":"HIV DNA Vaccine: Stepwise improvements make a difference","volume":"2","author":"Felber","year":"2014","journal-title":"Vaccines"},{"key":"10.1016\/j.isci.2025.112232_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-4939-6481-9_6","article-title":"Nucleoside Modified mRNA Vaccines for Infectious Diseases","volume":"1499","author":"Pardi","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.isci.2025.112232_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7040132","article-title":"Advances in RNA Vaccines for Preventive Indications: A Case Study of A Vaccine Against Rabies","volume":"7","author":"Armbruster","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.isci.2025.112232_bib4","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics--developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2025.112232_bib5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.cell.2021.02.030","article-title":"Novel approaches for vaccine development","volume":"184","author":"Gebre","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112232_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.coi.2020.01.006","article-title":"DNA vaccines: prime time is now","volume":"65","author":"Gary","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7020037","article-title":"A Comparison of Plasmid DNA and mRNA as Vaccine Technologies","volume":"7","author":"Liu","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.isci.2025.112232_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4161\/hv.2.2.2620","article-title":"Preclinical and clinical safety studies on DNA vaccines","volume":"2","author":"Schalk","year":"2006","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.isci.2025.112232_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-4939-6481-9_12","article-title":"Enhanced Delivery of DNA or RNA Vaccines by Electroporation","volume":"1499","author":"Broderick","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.isci.2025.112232_bib10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fimmu.2013.00354","article-title":"Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants","volume":"4","author":"Flingai","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/QAD.0b013e3282f42461","article-title":"Cytokines as adjuvants for improving anti-HIV responses","volume":"22","author":"Morrow","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.isci.2025.112232_bib12","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.4161\/hv.21407","article-title":"IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T\u00a0cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques","volume":"8","author":"Jalah","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.isci.2025.112232_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8040741","article-title":"Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP((R)) DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults","volume":"8","author":"Edupuganti","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.isci.2025.112232_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202753","article-title":"Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial","volume":"13","author":"Elizaga","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.112232_bib15","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1089\/hum.2018.065","article-title":"Rapid and High Recall of T Cell Responses upon DNA or rMVA Boost in Macaques Vaccinated with HIV\/SIV Conserved Element CE gag DNA Vaccine","volume":"29","author":"Hu","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.isci.2025.112232_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091550","article-title":"DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaques","volume":"9","author":"Jalah","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.112232_bib17","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1016\/j.vaccine.2010.04.064","article-title":"Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization","volume":"28","author":"Patel","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.112232_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/jmp.12123","article-title":"DNA Vaccination by Intradermal Electroporation Induces Long-lasting Immune Responses in Rhesus Macaques","volume":"43","author":"Kulkarni","year":"2014","journal-title":"J.\u00a0Med. Primatol."},{"key":"10.1016\/j.isci.2025.112232_bib19","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.4161\/hv.25473","article-title":"Comparison of Intradermal and Intramuscular Delivery of SIV Env DNA by in\u00a0vivo Electroporation in Macaques","volume":"9","author":"Kulkarni","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.isci.2025.112232_bib20","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.4161\/hv.25442","article-title":"Vaccination with Vaxfectin\u00ae adjuvanted SIV DNA Induces Long-lasting Humoral Immune Responses Able to Reduce SIVmac251 Viremia","volume":"9","author":"Kulkarni","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.isci.2025.112232_bib21","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1056\/NEJMc2115597","article-title":"Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge","volume":"385","author":"Baden","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2025.112232_bib22","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates","volume":"383","author":"Corbett","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2025.112232_bib23","article-title":"RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study","author":"Walsh","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.isci.2025.112232_bib24","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2025.112232_bib25","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.ymthe.2023.06.017","article-title":"A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation","volume":"31","author":"Kimura","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2025.112232_bib26","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ymthe.2023.02.022","article-title":"Evaluation of repRNA vaccine for induction and in utero transfer of maternal antibodies in a pregnant rabbit model","volume":"31","author":"Khandhar","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2025.112232_bib27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.omtm.2020.06.011","article-title":"Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection","volume":"18","author":"Erasmus","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.isci.2025.112232_bib28","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.ymthe.2018.07.010","article-title":"A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika","volume":"26","author":"Erasmus","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2025.112232_bib29","article-title":"A replicon RNA vaccine can induce durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned","volume":"19","author":"O'Connor","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2025.112232_bib30","article-title":"A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques","volume":"12","author":"O'Connor","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib31","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/s41591-024-02955-2","article-title":"An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2\/3 randomized trial","volume":"30","author":"Saraf","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2025.112232_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009701","article-title":"Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques","volume":"17","author":"Rosati","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2025.112232_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc9396","article-title":"An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T\u00a0cell responses in mice and nonhuman primates","volume":"12","author":"Erasmus","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2025.112232_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107624","article-title":"Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge","volume":"31","author":"Felber","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2025.112232_bib35","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1016\/j.vaccine.2013.04.037","article-title":"HIV\/SIV DNA Vaccine Combined with Protein in a Co-immunization Protocol Elicits Highest Humoral Responses to Envelope in Mice and Macaques","volume":"31","author":"Li","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.112232_bib36","doi-asserted-by":"crossref","first-page":"15831","DOI":"10.1073\/pnas.0902628106","article-title":"DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge","volume":"106","author":"Rosati","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112232_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109120","article-title":"Role of nuclear localization in the regulation and function of T-bet and Eomes in exhausted CD8 T\u00a0cells","volume":"35","author":"McLane","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2025.112232_bib38","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ni1268","article-title":"Effector and memory CD8+ T\u00a0cell fate coupled by T-bet and eomesodermin","volume":"6","author":"Intlekofer","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib39","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nri3536","article-title":"T-bet: a bridge between innate and adaptive immunity","volume":"13","author":"Lazarevic","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cytogfr.2009.11.007","article-title":"The chemokine system in cancer biology and therapy","volume":"21","author":"Mantovani","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.isci.2025.112232_bib41","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00018-023-04715-w","article-title":"A review of the pleiotropic actions of the IFN-inducible CXC chemokine receptor 3 ligands in the synovial microenvironment","volume":"80","author":"Dillemans","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.isci.2025.112232_bib43","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102763","article-title":"Interleukin 1alpha: a comprehensive review on the role of IL-1alpha in the pathogenesis and treatment of autoimmune and inflammatory diseases","volume":"20","author":"Cavalli","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.isci.2025.112232_bib45","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1073\/pnas.1520112113","article-title":"CXCL13 is a plasma biomarker of germinal center activity","volume":"113","author":"Havenar-Daughton","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112232_bib46","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1042\/BCJ20180565","article-title":"Signalling circuits that direct early B-cell development","volume":"476","author":"Petkau","year":"2019","journal-title":"Biochem. J."},{"key":"10.1016\/j.isci.2025.112232_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.105929","article-title":"Step-dose IL-7 treatment promotes systemic expansion of T\u00a0cells and alters immune cell landscape in blood and lymph nodes","volume":"26","author":"Pandit","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.isci.2025.112232_bib48","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.4049\/jimmunol.1203032","article-title":"Cutting edge: STAT1 is required for IL-6-mediated Bcl6 induction for early follicular helper cell differentiation","volume":"190","author":"Choi","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071525","article-title":"The Flt3L\/Flt3 Axis in Dendritic Cell Biology and Cancer Immunotherapy","volume":"13","author":"Cueto","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2025.112232_bib50","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/imcb.12484","article-title":"Dendritic cell Flt3 - regulation, roles and repercussions for immunotherapy","volume":"99","author":"Wilson","year":"2021","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.isci.2025.112232_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109504","article-title":"Systemic IL-15, IFN-gamma, and IP-10\/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients","volume":"36","author":"Bergamaschi","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2025.112232_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1292568","article-title":"Rapid Transient and Longer-Lasting Innate Cytokine Changes Associated with Adaptive Immunity after Repeated SARS-CoV-2 BNT162b2 mRNA Vaccinations","volume":"14","author":"Rosati","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.899972","article-title":"Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies","volume":"13","author":"Bergamaschi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113994","article-title":"Identification of macaque dendritic cell precursors in blood and tissue reveals their dysregulation in early SIV infection","volume":"43","author":"Gardet","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2025.112232_bib55","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.4049\/jimmunol.1500522","article-title":"Differentiation Kinetics of Blood Monocytes and Dendritic Cells in Macaques: Insights to Understanding Human Myeloid Cell Development","volume":"195","author":"Sugimoto","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors","volume":"356","author":"Villani","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.112232_bib57","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.immuni.2020.06.002","article-title":"Transcriptional and Functional Analysis of CD1c(+) Human Dendritic Cells Identifies a CD163(+) Subset Priming CD8(+)CD103(+) T Cells","volume":"53","author":"Bourdely","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2025.112232_bib58","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.cell.2024.04.009","article-title":"FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice","volume":"187","author":"Momenilandi","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112232_bib59","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/jcp.24824","article-title":"Flt3 ligand induces monocyte proliferation and enhances the function of monocyte-derived dendritic cells in\u00a0vitro","volume":"230","author":"Kim","year":"2015","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.isci.2025.112232_bib60","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/bmt.2015.74","article-title":"Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers","volume":"50","author":"Anandasabapathy","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.isci.2025.112232_bib61","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.4049\/jimmunol.157.12.5613","article-title":"Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3","volume":"157","author":"Garcia-Zepeda","year":"1996","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib62","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.it.2006.04.004","article-title":"Production of interferon-gamma by myeloid cells--fact or fancy?","volume":"27","author":"Bogdan","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib63","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3389\/fimmu.2018.01867","article-title":"Identifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8(+) T Cell Accumulation in the Omentum of Obesity-Associated Cancer Patients","volume":"9","author":"Conroy","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib64","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/s10165-006-0471-9","article-title":"Fractalkine in rheumatoid arthritis and allied conditions","volume":"16","author":"Umehara","year":"2006","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.isci.2025.112232_bib65","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1073\/pnas.1611958114","article-title":"Essential role of immobilized chemokine CXCL12 in the regulation of the humoral immune response","volume":"114","author":"Barinov","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112232_bib66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.imbio.2005.05.001","article-title":"Tuning of macrophage responses by Stat3-inducing cytokines: molecular mechanisms and consequences in infection","volume":"210","author":"Lang","year":"2005","journal-title":"Immunobiology"},{"key":"10.1016\/j.isci.2025.112232_bib67","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi9768","article-title":"An IL-9-pulmonary macrophage axis defines the allergic lung inflammatory environment","volume":"7","author":"Fu","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib68","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10787-013-0177-5","article-title":"The multiple faces of CCL13 in immunity and inflammation","volume":"21","author":"Mendez-Enriquez","year":"2013","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.isci.2025.112232_bib69","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1182\/blood-2009-12-258186","article-title":"The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression","volume":"117","author":"Sanchez-Martin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.isci.2025.112232_bib70","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3389\/fimmu.2019.01322","article-title":"CXCR5+ CD8\u00a0T Cells: Protective or Pathogenic?","volume":"10","author":"Valentine","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102690","article-title":"CD8 follicular T\u00a0cells localize throughout the follicle during germinal center reactions and maintain cytolytic and helper properties","volume":"123","author":"Valentine","year":"2021","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.isci.2025.112232_bib72","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ni.3543","article-title":"CXCR5(+) follicular cytotoxic T\u00a0cells control viral infection in B cell follicles","volume":"17","author":"Leong","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib73","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature19317","article-title":"Follicular CXCR5- expressing CD8(+) T\u00a0cells curtail chronic viral infection","volume":"537","author":"He","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.112232_bib74","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3389\/fimmu.2018.01272","article-title":"Tfh1 Cells in Germinal Centers During Chronic HIV\/SIV Infection","volume":"9","author":"Velu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib75","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.4049\/jimmunol.2100082","article-title":"CXCR5(+)CD8(+) T\u00a0cells: A Review of their Antibody Regulatory Functions and Clinical Correlations","volume":"206","author":"Elzein","year":"2021","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib76","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","article-title":"CXCR3 in T\u00a0cell function","volume":"317","author":"Groom","year":"2011","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.isci.2025.112232_bib77","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.isci.2025.112232_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110266","article-title":"CXCR3 regulates stem and proliferative CD8+ T\u00a0cells during chronic infection by promoting interactions with DCs in splenic bridging channels","volume":"38","author":"Bangs","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2025.112232_bib79","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1038\/s41467-019-12980-2","article-title":"CXCR3 enables recruitment and site-specific bystander activation of memory CD8(+) T\u00a0cells","volume":"10","author":"Maurice","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112232_bib80","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.20020437","article-title":"The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)\/CXCL12","volume":"198","author":"Vanbervliet","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2025.112232_bib81","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.112232_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1034764","article-title":"CXCR5(+)CD8 T\u00a0cells: Potential immunotherapy targets or drivers of immune-mediated adverse events?","volume":"9","author":"Turner","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.isci.2025.112232_bib83","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.192.11.1545","article-title":"Follicular B helper T\u00a0cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production","volume":"192","author":"Breitfeld","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2025.112232_bib84","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag2285","article-title":"Follicular CD8 T\u00a0cells accumulate in HIV infection and can kill infected cells in\u00a0vitro via bispecific antibodies","volume":"9","author":"Petrovas","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2025.112232_bib85","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41577-023-00893-7","article-title":"The role of transcription factors in shaping regulatory T\u00a0cell identity","volume":"23","author":"Trujillo-Ochoa","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib86","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1084\/jem.20141380","article-title":"BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms","volume":"212","author":"Hatzi","year":"2015","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2025.112232_bib87","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/cancers13040837","article-title":"Heterodimeric IL-15 in Cancer Immunotherapy","volume":"13","author":"Bergamaschi","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2025.112232_bib88","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.celrep.2016.10.085","article-title":"Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer","volume":"17","author":"Havenar-Daughton","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2025.112232_bib89","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.180819","article-title":"Focusing HIV-1 Gag T-cell responses to highly conserved regions by DNA vaccination in HVTN 119","volume":"9","author":"Kalams","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2025.112232_bib90","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137079","article-title":"Robust antibody and cellular responses induced by DNA-only vaccination for HIV","volume":"5","author":"De Rosa","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2025.112232_bib91","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.cell.2022.03.024","article-title":"Vaccine protection against the SARS-CoV-2 Omicron variant in macaques","volume":"185","author":"Chandrashekar","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112232_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.945706","article-title":"Comparative immunogenicity of an mRNA\/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques","volume":"13","author":"Valentin","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib93","article-title":"Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in\u00a0vivo","volume":"3","author":"Gary","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2025.112232_bib94","article-title":"Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-gamma, CXCL9 and CXCL10","volume":"8","author":"Bergamaschi","year":"2020","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.isci.2025.112232_bib95","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.4049\/jimmunol.1600143","article-title":"Induction of Th1-Biased T Follicular Helper (Tfh) Cells in Lymphoid Tissues during Chronic Simian Immunodeficiency Virus Infection Defines Functionally Distinct Germinal Center Tfh Cells","volume":"197","author":"Velu","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib96","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1073\/pnas.1621418114","article-title":"Dynamics of SIV-specific CXCR5+ CD8 T\u00a0cells during chronic SIV infection","volume":"114","author":"Mylvaganam","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112232_bib97","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1084\/jem.20121932","article-title":"Follicular helper T\u00a0cells serve as the major CD4 T\u00a0cell compartment for HIV-1 infection, replication, and production","volume":"210","author":"Perreau","year":"2013","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2025.112232_bib98","doi-asserted-by":"crossref","first-page":"9838","DOI":"10.1073\/pnas.88.21.9838","article-title":"Lymphoid organs function as major reservoirs for human immunodeficiency virus","volume":"88","author":"Pantaleo","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.112232_bib99","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-020-0274-9","article-title":"CD8(+) T\u00a0cells in HIV control, cure and prevention","volume":"20","author":"Collins","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib100","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ymthe.2025.01.008","article-title":"Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates","volume":"33","author":"Buckley","year":"2024","journal-title":"Mol Ther."},{"key":"10.1016\/j.isci.2025.112232_bib101","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1038\/s41467-024-49332-8","article-title":"Transient growth factor expression via mRNA in lipid nanoparticles promotes hepatocyte cell therapy to treat murine liver diseases","volume":"15","author":"Smith","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112232_bib102","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.3389\/fimmu.2019.02035","article-title":"Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases","volume":"10","author":"Kapellos","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib103","article-title":"The MHC class II antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.112232_bib104","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3389\/fimmu.2018.01643","article-title":"Current Concepts of Antigen Cross-Presentation","volume":"9","author":"Embgenbroich","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib105","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/imm.12912","article-title":"The versatility of\u00a0the CD1 lipid antigen presentation pathway","volume":"154","author":"Chancellor","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.isci.2025.112232_bib106","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167955","article-title":"Durability of immune responses to mRNA booster vaccination against COVID-19","volume":"133","author":"Arunachalam","year":"2023","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.isci.2025.112232_bib107","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3390\/v13091844","article-title":"Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma","volume":"13","author":"Thomopoulos","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2025.112232_bib108","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejim.2021.05.010","article-title":"SARS-CoV-2 Antibody Kinetics Eight Months from COVID-19 \u039fnset: Persistence of Spike Antibodies but Loss of Neutralizing Antibodies in 24% of Convalescent Plasma Donors","volume":"89","author":"Terpos","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.isci.2025.112232_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.793953","article-title":"Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14\u00a0months after SARS-CoV-2 infection","volume":"12","author":"Rosati","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib110","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev-immunol-101721-061120","article-title":"T Cell Responses to SARS-CoV-2","volume":"41","author":"Sette","year":"2023","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.isci.2025.112232_bib111","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1002\/ajh.26887","article-title":"XBB.1.5 neutralizing antibodies upon bivalent COVID-19 vaccination are similar to XBB but lower than BQ.1.1","volume":"98","author":"Devasundaram","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.isci.2025.112232_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.112232_bib113","first-page":"1","article-title":"The R Package geepack for Generalized Estimating Equations","volume":"15","author":"Halekoh","year":"2006","journal-title":"J.\u00a0Stat. Softw."},{"key":"10.1016\/j.isci.2025.112232_bib114","first-page":"726","article-title":"Pheatmap: pretty heatmaps","volume":"1","author":"Kolde","year":"2019","journal-title":"R package version"},{"key":"10.1016\/j.isci.2025.112232_bib115","first-page":"e24","article-title":"Package \u2018corrplot\u2019","volume":"56","author":"Wei","year":"2017","journal-title":"Statistician"},{"key":"10.1016\/j.isci.2025.112232_bib116","first-page":"1","article-title":"lmerTest Package: Tests in Linear Mixed Effects Models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J.\u00a0Stat. Softw."},{"key":"10.1016\/j.isci.2025.112232_bib117","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s42826-022-00143-2","article-title":"Hematological and biochemical reference intervals of wild-caught and inhouse adult Indian rhesus macaques (Macaca mulatta)","volume":"38","author":"Shah","year":"2022","journal-title":"Lab. Anim. Res."},{"key":"10.1016\/j.isci.2025.112232_bib118","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201181","article-title":"Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses","volume":"217","author":"Schmidt","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2025.112232_bib119","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/s41590-024-01875-0","article-title":"Distinct SIV-specific CD8(+) T\u00a0cells in the lymph node exhibit simultaneous effector and stem-like profiles and are associated with limited SIV persistence","volume":"25","author":"Strongin","year":"2024","journal-title":"Nat. Immunol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225004936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225004936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:20:34Z","timestamp":1778901634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225004936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2589004225004936"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.112232","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly immunogenic DNA\/LION nanocarrier vaccine potently activates lymph nodes inducing long-lasting immunity in macaques","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.112232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112232"}}